These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 31051330)

  • 1. The Economic Burden of Chronic Obstructive Pulmonary Disease in the Asia-Pacific Region: A Systematic Review.
    Woo L; Smith HE; Sullivan SD
    Value Health Reg Issues; 2019 May; 18():121-131. PubMed ID: 31051330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The economic burden of chronic obstructive pulmonary disease (COPD) in the USA, Europe, and Asia: results from a systematic review of the literature.
    Anees Ur Rehman ; Ahmad Hassali MA; Muhammad SA; Shah S; Abbas S; Hyder Ali IAB; Salman A
    Expert Rev Pharmacoecon Outcomes Res; 2020 Dec; 20(6):661-672. PubMed ID: 31596632
    [No Abstract]   [Full Text] [Related]  

  • 3. The economic impact of exacerbations of chronic obstructive pulmonary disease and exacerbation definition: a review.
    Toy EL; Gallagher KF; Stanley EL; Swensen AR; Duh MS
    COPD; 2010 Jun; 7(3):214-28. PubMed ID: 20486821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indirect costs in chronic obstructive pulmonary disease: a review of the economic burden on employers and individuals in the United States.
    Patel JG; Nagar SP; Dalal AA
    Int J Chron Obstruct Pulmon Dis; 2014; 9():289-300. PubMed ID: 24672234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic Burden of Chronic Obstructive Pulmonary Disease (COPD): A Systematic Literature Review.
    Iheanacho I; Zhang S; King D; Rizzo M; Ismaila AS
    Int J Chron Obstruct Pulmon Dis; 2020; 15():439-460. PubMed ID: 32161455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost impact of COPD in Japan: opportunities and challenges?
    Nishimura S; Zaher C
    Respirology; 2004 Nov; 9(4):466-73. PubMed ID: 15612957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuing to Confront COPD International Patient Survey: Economic Impact of COPD in 12 Countries.
    Foo J; Landis SH; Maskell J; Oh YM; van der Molen T; Han MK; Mannino DM; Ichinose M; Punekar Y
    PLoS One; 2016; 11(4):e0152618. PubMed ID: 27092775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The economic burden of chronic obstructive pulmonary disease from 2004 to 2013.
    Kim J; Lee TJ; Kim S; Lee E
    J Med Econ; 2016; 19(2):103-10. PubMed ID: 26414920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of the economic burden of COPD in the U.S.: a review and synthesis of the literature.
    Foster TS; Miller JD; Marton JP; Caloyeras JP; Russell MW; Menzin J
    COPD; 2006 Dec; 3(4):211-8. PubMed ID: 17361502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased burden of disease and role of health economics: Asia-pacific region.
    Shah S; Abbas G; Hanif M; Anees-Ur-Rehman ; Zaman M; Riaz N; Altaf A; Hassan SU; Saleem U; Shah A
    Expert Rev Pharmacoecon Outcomes Res; 2019 Oct; 19(5):517-528. PubMed ID: 31401898
    [No Abstract]   [Full Text] [Related]  

  • 11. Economic burden of osteoporosis-related hip fracture in Asia: a systematic review.
    Mohd-Tahir NA; Li SC
    Osteoporos Int; 2017 Jul; 28(7):2035-2044. PubMed ID: 28314898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic Burden of Multiple Sclerosis in Low- and Middle-Income Countries: A Systematic Review.
    Dahham J; Rizk R; Kremer I; Evers SMAA; Hiligsmann M
    Pharmacoeconomics; 2021 Jul; 39(7):789-807. PubMed ID: 33956330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic review of humanistic and economic burden of symptomatic chronic obstructive pulmonary disease.
    Srivastava K; Thakur D; Sharma S; Punekar YS
    Pharmacoeconomics; 2015 May; 33(5):467-88. PubMed ID: 25663178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Healthcare costs with tiotropium plus usual care versus usual care alone following 1 year of treatment in patients with chronic obstructive pulmonary disorder (COPD).
    Friedman M; Menjoge SS; Anton SF; Kesten S
    Pharmacoeconomics; 2004; 22(11):741-9. PubMed ID: 15250751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical, humanistic, and economic burden of chronic obstructive pulmonary disease (COPD) in Canada: a systematic review.
    Dang-Tan T; Ismaila A; Zhang S; Zarotsky V; Bernauer M
    BMC Res Notes; 2015 Sep; 8():464. PubMed ID: 26391471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic analysis of the Confronting COPD survey: an overview of results.
    Wouters EF
    Respir Med; 2003 Mar; 97 Suppl C():S3-14. PubMed ID: 12647938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic burden of chronic obstructive pulmonary disease.
    Teo WS; Tan WS; Chong WF; Abisheganaden J; Lew YJ; Lim TK; Heng BH
    Respirology; 2012 Jan; 17(1):120-6. PubMed ID: 21954985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Costs of chronic obstructive pulmonary disease in patients treated in ambulatory care in Poland].
    Jahnz-Różyk K; Targowski T; From S; Faluta T; Borowiec L
    Pneumonol Alergol Pol; 2011; 79(5):337-42. PubMed ID: 21861257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of Life and Economic Burden of Respiratory Disease in Asia-Pacific-Asia-Pacific Burden of Respiratory Diseases Study.
    Wang Y; Ghoshal AG; Bin Abdul Muttalif AR; Lin HC; Thanaviratananich S; Bagga S; Faruqi R; Sajjan S; Brnabic AJ; Dehle FC; Cho SH
    Value Health Reg Issues; 2016 May; 9():72-77. PubMed ID: 27881264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic burden of hepatitis C-associated diseases: Europe, Asia Pacific, and the Americas.
    El Khoury AC; Wallace C; Klimack WK; Razavi H
    J Med Econ; 2012; 15(5):887-96. PubMed ID: 22458755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.